AZARET VILLEDA: Open Payments
NPI 1538824412 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$620 in 20 payments from 13 companies in 2025. Trend: 2023 $528 · 2024 $872 · 2025 $620
Food & beverage: $620
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $169 |
| Sequel Med Tech, LLC | 2 | $114 |
| BETA BIONICS, INC. | 2 | $69 |
| Xeris Pharmaceuticals, Inc. | 2 | $48 |
| RECORDATI_RARE_DISEASES_INC. | 2 | $43 |
| Lilly USA, LLC | 1 | $32 |
| Amphastar Pharmaceuticals, Inc. | 1 | $24 |
| Medtronic, Inc. | 1 | $23 |
| Amgen Inc. | 1 | $23 |
| Antares Pharma, Inc. | 1 | $22 |
Products named: Wegovy, TWIIST, iLet Bionic Pancreas, GVOKE HYPOPEN, JARDIANCE, Ozempic, SIGNIFOR LAR, MINIMED 780G.
Industry payments across TX — which companies pay providers there.
